457
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Prevalence of Multidrug-Resistant Pathogens Causing Neonatal Early and Late Onset Sepsis, a Retrospective Study from the Tertiary Referral Children’s Hospital

ORCID Icon, , , , , ORCID Icon & ORCID Icon show all
Pages 4213-4225 | Received 06 Apr 2023, Accepted 17 Jun 2023, Published online: 29 Jun 2023

References

  • Fleiss N, Coggins SA, Lewis AN, et al. Evaluation of the neonatal sequential organ failure assessment and mortality risk in preterm infants with late-onset infection. JAMA Netw Open. 2021;4(2):e2036518.
  • Shane AL, Sánchez PJ, Stoll BJ. Neonatal sepsis. Lancet. 2017;390(10104):1770–1780.
  • Wang H, Abajobir AA, Abate KH. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1084–1150.
  • Vos T, Lim SS, Abbafati C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–1222.
  • He C, Liu L, Chu Y, et al. National and subnational all-cause and cause-specific child mortality in China, 1996-2015: a systematic analysis with implications for the Sustainable Development Goals. Lancet Glob Health. 2017;5(2):e186–e197.
  • Dong Y, Basmaci R, Titomanlio L, et al. Neonatal sepsis: within and beyond China. Chin Med J. 2020;133(18):2219–2228.
  • Juliana AE, Holband N, Lissone NPA, et al. Incidence of early and late onset neonatal sepsis in suriname: a national tertiary hospital birth-cohort study. Pediatr Infect Dis J. 2022;41(12):1007–1011.
  • Yadav P, Yadav SK. Progress in Diagnosis and Treatment of Neonatal Sepsis: a Review Article. JNMA J Nepal Med Assoc. 2022;60(247):318–324.
  • Mariani M, Parodi A, Minghetti D, et al. Early and Late Onset Neonatal Sepsis: epidemiology and Effectiveness of Empirical Antibacterial Therapy in a III Level Neonatal Intensive Care Unit. Antibiotics. 2022;11(2):65.
  • Pace E, Yanowitz T. Infections in the NICU: neonatal sepsis. Semin Pediatr Surg. 2022;31(4):151200.
  • Ren Y, Chakraborty T, Doijad S, et al. Multi-label classification for multi-drug resistance prediction of Escherichia coli. Comput Struct Biotechnol J. 2022;20:1264–1270.
  • Golli AL, Cristea OM, Zlatian O, et al. Prevalence of Multidrug-Resistant Pathogens Causing Bloodstream Infections in an Intensive Care Unit. Infect Drug Resist. 2022;15:5981–5992.
  • Robledo J, Maldonado N, Robledo C, et al. Changes in Antimicrobial Resistance and Etiology of Blood Culture Isolates: results of a Decade (2010-2019) of Surveillance in a Northern Region of Colombia. Infect Drug Resist. 2022;15:6067–6079.
  • Hu F, Yuan L, Yang Y, et al. A multicenter investigation of 2773 cases of bloodstream infections based on China antimicrobial surveillance network (CHINET). Front Cell Infect Microbiol. 2022;12:1075185.
  • Haddad S, Jabbour JF, Hindy JR, et al. Bacterial bloodstream infections and patterns of resistance in patients with haematological malignancies at a tertiary centre in Lebanon over 10 years. J Glob Antimicrob Resist. 2021;27:228–235.
  • Simonsen KA, Anderson-Berry AL, Delair SF, et al. Early-onset neonatal sepsis. Clin Microbiol Rev. 2014;27(1):21–47.
  • National Institute for Health and Care Excellence. Clinical Guidelines. Neonatal Infection: Antibiotics for Prevention and Treatment. London: National Institute for Health and Care Excellence (NICE) Copyright © NICE 2021; 2021.
  • Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281.
  • Rafailidis PI, Kofteridis D. Proposed amendments regarding the definitions of multidrug-resistant and extensively drug-resistant bacteria. Expert Rev Anti Infect Ther. 2022;20(2):139–146.
  • Fraimow HS, Tsigrelis C. Antimicrobial resistance in the intensive care unit: mechanisms, epidemiology, and management of specific resistant pathogens. Crit Care Clin. 2011;27(1):163–205.
  • CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 31th ed. Wayne: Clinical and Laboratory Standards Institute; 2021.
  • Ren Z, Yang S, Han J, et al. Reduction of antibiotic use and multi-drug resistance bacteria infection in neonates after improvement of antibiotics use strategy in a level 4 neonatal intensive care unit in southern China. Eur J Clin Microbiol Infect Dis. 2023;42(1):87–98.
  • Panigrahi K, Pathi BK, Poddar N, et al. Colistin resistance among multi-drug resistant gram-negative bacterial isolates from different clinical samples of ICU patients: prevalence and clinical outcomes. Cureus. 2022;14(8):e28317.
  • Al-Sunaidar KA, Aziz NA, Hassan Y, et al. Association of multidrug resistance bacteria and clinical outcomes of adult patients with sepsis in the intensive care unit. Trop Med Infect Dis. 2022;7(11):98.
  • Kim HJ, Oh DK, Lim SY, et al. Antibiogram of multidrug-resistant bacteria based on sepsis onset location in Korea: a multicenter cohort study. J Korean Med Sci. 2023;38(10):e75.
  • Legese MH, Asrat D, Swedberg G, et al. Sepsis: emerging pathogens and antimicrobial resistance in Ethiopian referral hospitals. Antimicrob Resist Infect Control. 2022;11(1):83.
  • Qiu Y, Yang J, Chen Y, et al. Microbiological profiles and antimicrobial resistance patterns of pediatric bloodstream pathogens in China, 2016-2018. Eur J Clin Microbiol Infect Dis. 2021;40(4):739–749.
  • Oxman D, Lohr K, Gupta E, et al. Incidence of multidrug resistant infections in emergency department patients with suspected sepsis. Am J Med Sci. 2020;360(6):650–655.
  • Størdal EH, Solevåg AL, Bjørnholt JV, et al. Sepsis treatment options identified by 10-year study of microbial isolates and antibiotic susceptibility in a level-four neonatal intensive care unit. Acta Paediatr. 2022;111(3):519–526.
  • Wang J, Zhang H, Yan J, et al. Literature review on the distribution characteristics and antimicrobial resistance of bacterial pathogens in neonatal sepsis. J Matern Fetal Neonatal Med. 2022;35(5):861–870.
  • Zhou W, Niu D, Gao S, et al. Prevalence, biofilm formation, and mass spectrometric characterization of linezolid-resistant Staphylococcus capitis isolated from a tertiary hospital in China. J Glob Antimicrob Resist. 2023:56.
  • Gowda H, Norton R, White A, et al. Late-onset Neonatal Sepsis-A 10-year Review From North Queensland, Australia. Pediatr Infect Dis J. 2017;36(9):883–888.
  • Ji H, Yu Y, Huang L, et al. Pathogen Distribution and Antimicrobial Resistance of Early Onset Sepsis in Very Premature Infants: a Real-World Study. Infect Dis Ther. 2022;11(5):1935–1947.
  • Köstlin-Gille N, Härtel C, Haug C, et al. Epidemiology of early and late onset neonatal sepsis in very low birthweight infants: data from the German neonatal network. Pediatr Infect Dis J. 2021;40(3):255–259.
  • França A. The Role of Coagulase-Negative Staphylococci Biofilms on Late-Onset Sepsis: current Challenges and Emerging Diagnostics and Therapies. Antibiotics. 2023;12(3):23.
  • Wong JR, Bauer KA, Mangino JE, et al. Antimicrobial stewardship pharmacist interventions for coagulase-negative staphylococci positive blood cultures using rapid polymerase chain reaction. Ann Pharmacother. 2012;46(11):1484–1490.
  • Aleidan FAS, Alkhelaifi H, Alsenaid A, et al. Incidence and risk factors of carbapenem-resistant Enterobacteriaceae infection in intensive care units: a matched case-control study. Expert Rev Anti Infect Ther. 2021;19(3):393–398.
  • Chaurasia S, Sivanandan S, Agarwal R, et al. Neonatal sepsis in South Asia: huge burden and spiralling antimicrobial resistance. BMJ. 2019;364:k5314.
  • Liu J, Fang Z, Yu Y, et al. Pathogens distribution and antimicrobial resistance in bloodstream infections in twenty-five neonatal intensive care units in China, 2017-2019. Antimicrob Resist Infect Control. 2021;10(1):121.
  • Narimisa N, Goodarzi F, Bavari S. Prevalence of colistin resistance of Klebsiella pneumoniae isolates in Iran: a systematic review and meta-analysis. Ann Clin Microbiol Antimicrob. 2022;21(1):29.
  • Ardebili A, Izanloo A, Rastegar M. Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy? Expert Rev Anti Infect Ther. 2023;21(4):387–429.
  • Liu YC, Lu CY, Yen TY, et al. Clinical characteristics and outcomes of carbapenem-resistant Enterobacterales bacteremia in pediatric patients. J Microbiol Immunol Infect. 2023;56(1):84–92.
  • Della Rocca MT, Panetta V, Durante A, et al. Pathogens distribution and antimicrobial resistance pattern of blood stream infections in Southern Italian hospital, 2016-2021 surveillance. New Microbiol. 2023;46(1):29–36.
  • Chen CH, Wu PH, Lu MC, et al. National surveillance of antimicrobial susceptibilities to ceftaroline, dalbavancin, telavancin, tedizolid, eravacycline, omadacycline, and other comparator antibiotics, and genetic characteristics of bacteremic Staphylococcus aureus isolates in adults: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) program in 2020. Int J Antimicrob Agents. 2023;61(4):106745.
  • Ohnuma T, Chihara S, Costin B, et al. Association of Appropriate Empirical Antimicrobial Therapy With In-Hospital Mortality in Patients With Bloodstream Infections in the US. JAMA Netw Open. 2023;6(1):e2249353.
  • Austin ED, Sullivan SS, Macesic N, et al. Reduced Mortality of Staphylococcus aureus Bacteremia in a Retrospective Cohort Study of 2139 Patients: 2007-2015. Clin Infect Dis. 2020;70(8):1666–1674.
  • Gao K, Fu J, Guan X, et al. Incidence, Bacterial Profiles, And Antimicrobial Resistance Of Culture-Proven Neonatal Sepsis In South China. Infect Drug Resist. 2019;12:3797–3805.
  • Kufel WD, Parsels KA, Blaine BE, et al. Vancomycin plus ceftaroline for persistent methicillin-resistant Staphylococcus aureus bacteremia. Pharmacotherapy. 2023;43(1):15–23.
  • Patel D, Brown ML, Edwards S, et al. Outcomes of Daptomycin Plus Ceftaroline Versus Alternative Therapy for Persistent Methicillin-resistant Staphylococcus aureus (MRSA) Bacteraemia. Int J Antimicrob Agents. 2023;61(3):106735.
  • Jena B, Singh SS, Behera SK, et al. To decipher the phytochemical agent and mechanism for Urginea indica mediated green synthesis of Ag nanoparticles and investigation of its antibacterial activity against Methicillin-resistant Staphylococcus aureus. Environ Res. 2023;216(Pt 4):114700.
  • Li T, Li X, Gao K, et al. Changes in pathogen distribution in the blood culture of neonates before and after the COVID-19 pandemic, Henan, China. J Infect. 2023;86(2):154–225.